Age, mean (SD), years | 9.2 (5.2) |
Age group, n (%) | |
1 month to <1 year | 1 (3) |
1–4 years | 5 (17) |
5–9 years | 9 (30) |
10–14 years | 10 (33) |
15–17 years | 4 (13) |
Girls, n (%) | 13 (43) |
Boys, n (%) | 17 (57) |
Vaccination, n (%) | |
Seasonal influenza | 4 (13) |
BCG | 30 (100) |
MMR | 29 (97) |
Total baseline chronic medical conditions, n (%) | 7 (23) |
Bronchial asthma | 3 (10) |
Congenital heart disease | 2 (7) |
Attention deficit disorder | 1 (3) |
Epilepsy | 1 (3) |
Immunosuppressant use before presentation, n (%) | 1 (3) |
Acute COVID-19 symptoms, n (%) | |
Fever, n (%) | |
≥37.5°C–38°C | 5 (17) |
38.1°C–39.0°C | 4 (13) |
>39.0°C | 5 (17) |
Rhinorrhoea | 8 (27) |
Cough | 7 (23) |
Fatigue | 7 (23) |
Headache | 7 (23) |
Stuffy nose | 7 (23) |
Sneezing | 6 (20) |
Sore throat | 6 (20) |
Diarrhoea | 4 (13) |
Anosmia | 3 (10) |
Ageusia | 2 (7) |
Poor appetite | 2 (7) |
Myalgia | 1 (3) |
Shortness of breath | 1 (3) |
Conjunctivitis | 1 (3) |
Ear pain | 1 (3) |
Vomiting | 1 (3) |
Severity of illness, n (%) | |
Asymptomatic | 5 (17) |
Mild | 24 (80) |
Moderate | 1 (3) |